Researchers have been excited about the medication , a groundbreaking dual compound showing promising outcomes in initial trials for body management. It works by modulating both pathways : GLP-1 and GIP, which , when activated , assist control appetite and boost metabolism . Initial observations suggest considerable weight reduction and potential i